The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Positron Emission Tomography (PET) in Oncology
Open accessAbstract
Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment during or after treatment end and radiotherapy planning. Moreover, the continuous technological progress of image generation and the introduction of sophisticated software to use PET scan as a biomarker paved the way to calculate new prognostic markers such as the metabolic tumor volume (MTV) and the total amount of tumor glycolysis (TLG). FDG-PET/CT proved more sensitive than contrast-enhanced CT scan in staging of several type of lymphoma or in detecting widespread tumor dissemination in several solid cancers, such as breast, lung, colon, ovary and head and neck carcinoma. As a consequence the stage of patients was upgraded, with a change of treatment in 10%–15% of them. One of the most evident advantages of FDG-PET was its ability to detect, very early during treatment, significant changes in glucose metabolism or even complete shutoff of the neoplastic cell metabolism as a surrogate of tumor chemosensitivity assessment. This could enable clinicians to detect much earlier the effectiveness of a given antineoplastic treatment, as compared to the traditional radiological detection of tumor shrinkage, which usually takes time and occurs much later.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
Nestle, U., Schaefer-Schuler, A., Kremp, S., Gröschel, A., Hellwig, D., Rübe, C., & Kirsch, C. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0252-x · Cited by 98
Benz, M., Herrmann, K., Walter, F., Garon, E. B., Reckamp, K. L., Figlin, R. A., Phelps, M. E., Weber, W., Czernin, J. G., & Allen-Auerbach, M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.095257 · Cited by 96
PET/MRI and PET/CT in follow-up of head and neck cancer patients
Queiroz, M. A., Hüllner, M. W., Kuhn, F. P., Huber, G., Meerwein, C. M., Kollias, S., von Schulthess, G. K., & Veit‐Haibach, P. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2707-9 · Cited by 95
Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association With Response
Kidd, E. A., Thomas, M., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.02.056 · Cited by 94
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
Walrand, S., Flux, G., Konijnenberg, M., Valkema, R., Krenning, E. P., Lhommel, R., Pauwels, S. A., & Jamar, F. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1771-7 · Cited by 88
Peare, R., Staff, R. T., & Heys, S. D. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0771-9 · Cited by 88
Xu, H., Chen, T., Wang, W.-Q., Wu, C., Liu, C., Long, J., Xu, J., Zhang, Y.-J., Chen, R.-H., Liu, L., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2688-8 · Cited by 88
An audit of the treatment of cancer of the oesophagus.
Sagar, P. M., Gauperaa, T., Sue-Ling, H. M., McMahon, M. J., & Johnston, D. (1994) · Gut · doi:10.1136/gut.35.7.941 · Cited by 87
PET Imaging of Proliferation with Pyrimidines
Tehrani, O. S., & Shields, A. F. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.112201 · Cited by 87
The impact of PET on the management of lung cancer: the referring physician's perspective.
Seltzer, M., Yap, C., Silverman, D. H. S., Meta, J., Schiepers, C. W., Phelps, M. E., Gambhir, S. S., Rao, J., Valk, P. E., & Czernin, J. G. (2002) · PubMed · Cited by 86
Keam, B., Im, S., Koh, Y., Han, S., Oh, D., Cho, N., Kim, J. H., Han, W., Kang, K. W., Moon, W. K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-452 · Cited by 83
Lee, D. H., Kim, S.-K., Lee, S., Lee, S. Y., Park, S. H., Kim, H. Y., Kang, K. W., Han, J., Kim, H. T., & Lee, J. S. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a99fde · Cited by 83
The role of PET/CT in cervical cancer
Herrera, F. G., & Prior, J. O. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00034 · Cited by 83
Surveillance of patients after initial treatment of ovarian cancer
Gadducci, A., & Cosio, S. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.12.008 · Cited by 81
Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
Contractor, K. B., & Aboagye, E. O. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057273 · Cited by 81
Aukema, T. S., Kappers, I., Olmos, R. A. V., Codrington, H., van Tinteren, H., van Pel, R., Klomp, H. M., & on behalf of the NEL Study Group (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076224 · Cited by 81
Quantitative techniques in 18FDG PET scanning in oncology
Castell, F. A., & Cook, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604330 · Cited by 80
Hendlisz, A., Golfinopoulos, V., Garcia, C., Covas, A., Emonts, P., Ameye, L., Paesmans, M., Deleporte, A., Machiels, G., Toussaint, E., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr554 · Cited by 78
Gallamini, A., Fiore, F., Sorasio, R., & Meignan, M. A. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903308072 · Cited by 77
Self-citationPET/CT in the Staging of the Non-Small-Cell Lung Cancer
Chao, F., & Zhang, H. (2012) · BioMed Research International · doi:10.1155/2012/783739 · Cited by 76
Prognostic factors in multiple myeloma.
Kyle, R. A. (1995) · PubMed · Cited by 75
Ovarian Cancer Management: The role of imaging and diagnostic challenges
Bharwani, N., Reznek, R. H., & Rockall, A. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.11.039 · Cited by 72
18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
Krause, B. J., Herrmann, K., Wieder, H. A., & Büschenfelde, C. M. Z. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057232 · Cited by 71
Fabel, M., von Tengg‐Kobligk, H., Giesel, F. L., Bornemann, L., Dicken, V., Kopp‐Schneider, A., Moser, C., Delorme, S., & Kauczor, H. (2008) · European Radiology · doi:10.1007/s00330-008-0866-4 · Cited by 69
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma
Chan, S.-C., Chang, J. T., Lin, C., Ng, S., Wang, H., Liao, C., Chang, C., Lin, S., & Yen, T. (2011) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283495662 · Cited by 67
Decoster, L., Schallier, D. C. C., Everaert, H., Nieboer, K., Meysman, M., Neyns, B., Mey, J. D., & Grève, J. D. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.02.015 · Cited by 66
DRIESKENS, O., Stroobants, S. G., Gysen, M., Vandenbosch, G., Mortelmans, L., & Vergote, I. B. (2003) · Gynecologic and Obstetric Investigation · doi:10.1159/000071525 · Cited by 66
Hospers, G. A. P., Punt, C. J. A., Tesselaar, M. E. T., Cats, A., Havenga, K., Leer, J. W. H., Marijnen, C. A. M., Jansen, E. P. M., van Krieken, H. H. J. M., Wiggers, T., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9396-6 · Cited by 66
Jayachandran, P., Pai, R. K., Quon, A. S. W., Graves, E. E., Krakow, T. E., La, T. H., Loo, B. W., Koong, A. C., & Chang, D. T. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.12.029 · Cited by 65
Bhosale, P., Peungjesada, S., Wei, W., Levenback, C. F., Schmeler, K. M., ROHREN, E. M., Macapinlac, H. A., & Iyer, R. B. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181e82a7f · Cited by 65
Prieto, E., Martí-Climent, J. M., Domínguez‐Prado, I., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085324 · Cited by 64
Clarke, T., Galaal, K. A., Bryant, A., & Naik, R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006119.pub3 · Cited by 63
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma
Kasamon, Y. L., & Wahl, R. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f5123d · Cited by 63
Mamede, M. H., Fakhri, G. E., de Abreu-e-Lima, P. C., Gandler, W., Nosé, V., & Gerbaudo, V. H. (2007) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0040-0 · Cited by 62
Martoni, A. A., Zamagni, C., Quercia, S., Rosati, M., Cacciari, N., Bernardi, A., Musto, A., Fanti, S., Santini, D., & Taffurelli, M. (2010) · Cancer · doi:10.1002/cncr.24820 · Cited by 61
Zhao, Q., Feng, Y., Mao, X., & Qie, M. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31829ee012 · Cited by 59
Beauregard, J., Williams, S., DeGrado, T. R., Roselt, P. D., & Hicks, R. J. (2010) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2010.02178.x · Cited by 58
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer
Fruscio, R., Sina, F. P., Dolci, C., Signorelli, M., Crivellaro, C., Dell’Anna, T., Cuzzocrea, M., Guerra, L., Milani, R., & Messa, C. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.09.024 · Cited by 57
Gao, S., Li, S., Yang, X., & Tang, Q. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.12.002 · Cited by 57
Matsumoto, I., Shirakawa, S., Shinzeki, M., Asari, S., Goto, T., Ajiki, T., Fukumoto, T., Kitajima, K., & Ku, Y. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.033 · Cited by 57
Blokhuis, T. J., Schaaf, M., van den Tol, M. P., Comans, E. F. I., Manoliu, R. A., & van der Sijp, J. R. M. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00855920410014623 · Cited by 55
18F-FDG PET/CT of Cervical Carcinoma
Patel, C. N., Nazir, S. A., Khan, Z. A., Gleeson, F. V., & Bradley, K. M. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.5084 · Cited by 55
Pinilla, I., León, N. G., del Val, L. D. C., Hernández‐Maraver, D., Rodríguez‐Vigil, B., Jover-Díaz, R., & Coya, J. (2011) · PubMed · Cited by 54
Meta-analysis of 18FDG PET-CT for nodal staging in patients with esophageal cancer
Shi, W., Wang, W., Wang, J., Cheng, H., & Huo, X. (2013) · Surgical Oncology · doi:10.1016/j.suronc.2013.02.003 · Cited by 52
A comparison of diagnostic imaging modalities for colorectal liver metastases
Bonanni, L., Carino, N. D. L., Deshpande, R., Ammori, B. J., Sherlock, D., Valle, J. W., Tam, E., & O'Reilly, D. A. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.12.023 · Cited by 51
Kato, K., Nihashi, T., Ikeda, M., Abe, S., Iwano, S., Itoh, S., Shimamoto, K., & Naganawa, S. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182817d9d · Cited by 47
Comparison of DWI and PET/CT in evaluation of lymph node metastasis in uterine cancer
Kitajima, K. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i5.207 · Cited by 46
Contemporary nuclear medicine imaging of neuroendocrine tumours
Wong, K. K., Waterfield, R. T., Marzola, M. C., Scarsbrook, A. F., Chowdhury, F. U., Gross, M. D., & Rubello, D. (2012) · Clinical Radiology · doi:10.1016/j.crad.2012.03.019 · Cited by 45
Menzel, C., Döbert, N., Hamscho, N., et al. (2004) · Strahlentherapie und Onkologie · doi:10.1007/s00066-004-1208-3 · Cited by 41
Meignan, M. A., Itti, E., Gallamini, A., & Haïoun, C. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903308056 · Cited by 41
Self-citationYoon, S. H., Goo, J. M., Lee, S. M., Park, C. M., Seo, H. J., & Cheon, G. J. (2013) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000062 · Cited by 39
Miyata, H., Yamasaki, M., Takahashi, T., Murakami, K., Tanaka, K., Kurokawa, Y., Nakajima, K., Takiguchi, S., Morii, E., Hatazawa, J., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3343-5 · Cited by 39
Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma
Gallamini, A. (2010) · Haematologica · doi:10.3324/haematol.2010.024885 · Cited by 39
Self-citationBaiocchi, G. L., Bertagna, F., Gheza, F., Grazioli, L., Calanducci, D., Giubbini, R., Portolani, N., & Giulini, S. M. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2234-5 · Cited by 36
Stone, W. Z., Wymer, D. C., & Canales, B. K. (2013) · Journal of Endourology · doi:10.1089/end.2013.0380 · Cited by 34
Patel, K., Hadar, N., Lee, J., Siegel, B. A., Hillner, B. E., & Lau, J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.119362 · Cited by 34
Choi, H. J., Kang, C. M., Lee, W. J., Song, S. Y., Cho, A. E.-H., Yun, M., Lee, J.-D., Kim, J. H., & Lee, J. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.6.1377 · Cited by 33
Chung, M. K., Jeong, H.-S., Son, Y., So, Y. K., Park, G. Y., Choi, J. Y., Hyun, S. H., Kim, H., Ko, Y. H., & Baek, C. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0621-3 · Cited by 32
Post-therapy surveillance and after-care in ovarian cancer
von Georgi, R., Schubert, K., Grant, P. S., & Münstedt, K. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00578-5 · Cited by 32
Chalaye, J., Luciani, A., Enache, C., Beaussart, P., Lhermite, C., Evangelista, E., Sasanelli, M., Safar, V., Meignan, M. A., Haïoun, C., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.900761 · Cited by 29
Hoekstra, O., van Lingen, A., Ossenkoppele, G., Golding, R., & Teule, G. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00171020 · Cited by 27
Role of Positron Emission Tomography/Computed Tomography in Breast Cancer
Bourgeois, A. C., Warren, L. A., Chang, T. T., Embry, S., Hudson, K. B., & BRADLEY, Y. C. (2013) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2013.06.003 · Cited by 26
FDG PET or PET/CT in patients with pancreatic cancer: when does it add to diagnostic CT or MRI?
Javery, O., Shyn, P. B., & Mortelé, K. J. (2012) · Clinical Imaging · doi:10.1016/j.clinimag.2012.07.005 · Cited by 22
Staging DLBCL: bone marrow biopsy or PET-CT?
Avigdor, A. (2013) · Blood · doi:10.1182/blood-2013-05-502575 · Cited by 19
Hendlisz, A., Golfinopoulos, V., Deleporte, A., Paesmans, M., Mansy, H. E., Garcia, C. A., Peeters, M., Annemans, L., Vandeputte, C., Maetens, M., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-190 · Cited by 15
Role of 18F-DOPA PET/CT in Diagnosis and Follow-up of Adrenal and Extra-adrenal Paragangliomas
Bacca, A., Chiacchio, S., Zampa, V., Carrara, D., Duce, V., Congregati, C., Simi, P., Taddei, S., Materazzi, G., Volterrani, D., et al. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000242 · Cited by 15
The Clinical Use of PET/CT in the Evaluation of Melanoma
Keu, K. V., & Iagaru, A. H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-727-3_30 · Cited by 14
Geurts, S., de Vegt, F., van Altena, A. V., Tjan-Heijnen, V., Massuger, L., Adang, E., van Dijck, J. V., & Verbeek, A. (2012) · International Journal of Gynecologic Cancer · doi:10.1097/igc.0b013e3182611451 · Cited by 11
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Cited by
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
Zong, W.-X., Rabinowitz, J. D., & White, E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.011 · Cited by 1,277
Molecular basis of ligand recognition and transport by glucose transporters
Deng, D., Sun, P., Yan, C., Ke, M., Jiang, X., Xiong, L., Ren, W., Hirata, K., Yamamoto, M., Fan, S., et al. (2015) · Nature · doi:10.1038/nature14655 · Cited by 384
Breast cancer detection using deep learning: Datasets, methods, and challenges ahead
din, N. M. U., Dar, R. A., Rasool, M., & Assad, A. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106073 · Cited by 363
Functional expression of sodium-glucose transporters in cancer
Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 329
Metadata
- Authors
- Gallamini, A., Zwarthoed, C., & Borra, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2014-09-29
- Volume
- 6
- Issue
- 4
- Pages
- 1821-1889
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2075660225
- Cited by
- 312
- References
- 270
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.